Dr. Wendy Harpham is a doctor of internal medicine, cancer survivor, and award-winning and best-selling author of books about cancer: Healthy Survivorship, recovery and late effects, and raising children when a parent has cancer. She is also a public speaker, patient advocate, and mother of three.
Some clinicians think investigational therapies administered in Phase I trials should not be called "treatment." To explain why I believe those therapies can, indeed, be called treatment, let's first look at the general idea of treatment.
I posted on this blog only twice in April, the month before my May 6th keynote at MD Anderson. What made the topic--"Talking with Patients about Phase I Trials"--so challenging that it consumed all my writing hours for most of this year?